[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Who Pays the Price? Race, Socioeconomic Factors, and Outcomes in Intracranial Tumor Care",
    "section": "",
    "text": "Study Objective: Investigate the association between race, income, and insurance status with outcomes among patients admitted with a principal diagnosis of intracranial tumors across U.S. hospitals from 2018 to 2020, while adjusting for demographic, clinical, and hospital-level factors.\nData Source: Cross-sectional analysis utilizing the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of intracranial tumors, identified using ICD-10 diagnosis codes for benign or malignant neoplasms of the brain and central nervous system, meninges, or eye and adnexa (D31.xx, D32.xx, D33.xx, C69.xx, C70.xx, C71.xx, C72.xx). Patients were categorized by race (White, Asian or Pacific Islander, Black, Hispanic, Other).\nOutcomes of Interest:\n\nIn-hospital Mortality\nLength of Stay (days)\nInflation-Adjusted Total Charge ($) [inflation adjusted to 2020 dollars using CPI data from the U.S. Bureau of Labor Statistics]\n\nStatistical Analysis: Multivariable regression models were performed to assess the independent associations of race, residential income quartile, and insurance payer type with each outcome, adjusting for:\n\nDemographics and Clinical Factors: Age, sex, tumor location (brain and central nervous system, meninges, or eye and adnexa), tumor type (benign or malignant), admission type (elective or non-elective), and Elixhauser comorbidity index.\nHospital Characteristics: Hospital region, bed size, and teaching status.\n\nSoftware: Analyses were conducted using the R Statistical Language (Version 4.4.1; R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was set at a two-tailed alpha of 0.05."
  },
  {
    "objectID": "quarto/index.html#overview",
    "href": "quarto/index.html#overview",
    "title": "Who Pays the Price? Race, Socioeconomic Factors, and Outcomes in Intracranial Tumor Care",
    "section": "",
    "text": "Study Objective: Investigate the association between race, income, and insurance status with outcomes among patients admitted with a principal diagnosis of intracranial tumors across U.S. hospitals from 2018 to 2020, while adjusting for demographic, clinical, and hospital-level factors.\nData Source: Cross-sectional analysis utilizing the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of intracranial tumors, identified using ICD-10 diagnosis codes for benign or malignant neoplasms of the brain and central nervous system, meninges, or eye and adnexa (D31.xx, D32.xx, D33.xx, C69.xx, C70.xx, C71.xx, C72.xx). Patients were categorized by race (White, Asian or Pacific Islander, Black, Hispanic, Other).\nOutcomes of Interest:\n\nIn-hospital Mortality\nLength of Stay (days)\nInflation-Adjusted Total Charge ($) [inflation adjusted to 2020 dollars using CPI data from the U.S. Bureau of Labor Statistics]\n\nStatistical Analysis: Multivariable regression models were performed to assess the independent associations of race, residential income quartile, and insurance payer type with each outcome, adjusting for:\n\nDemographics and Clinical Factors: Age, sex, tumor location (brain and central nervous system, meninges, or eye and adnexa), tumor type (benign or malignant), admission type (elective or non-elective), and Elixhauser comorbidity index.\nHospital Characteristics: Hospital region, bed size, and teaching status.\n\nSoftware: Analyses were conducted using the R Statistical Language (Version 4.4.1; R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was set at a two-tailed alpha of 0.05."
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Who Pays the Price? Race, Socioeconomic Factors, and Outcomes in Intracranial Tumor Care",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWhite N = 134,8001\nAsian or Pacific Islander N = 6,6751\nBlack N = 18,6901\nHispanic N = 19,1051\nOther N = 8,2551\np-value2\n\n\n\n\nAge, y\n57 (19)\n52 (20)\n54 (20)\n49 (22)\n50 (22)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n67,200 (50%)\n3,860 (58%)\n10,645 (57%)\n10,460 (55%)\n4,190 (51%)\n\n\n\n\n    Male\n67,595 (50%)\n2,815 (42%)\n8,045 (43%)\n8,645 (45%)\n4,065 (49%)\n\n\n\n\nTumor location\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Brain and central nervous system\n91,745 (68%)\n3,920 (59%)\n9,335 (50%)\n12,480 (65%)\n5,520 (67%)\n\n\n\n\n    Eye and adnexa\n1,850 (1.4%)\n65 (1.0%)\n220 (1.2%)\n350 (1.8%)\n175 (2.1%)\n\n\n\n\n    Meninges\n41,205 (31%)\n2,690 (40%)\n9,135 (49%)\n6,275 (33%)\n2,560 (31%)\n\n\n\n\nTumor type\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Benign\n50,615 (38%)\n3,560 (53%)\n9,900 (53%)\n7,920 (41%)\n3,165 (38%)\n\n\n\n\n    Malignant\n84,185 (62%)\n3,115 (47%)\n8,790 (47%)\n11,185 (59%)\n5,090 (62%)\n\n\n\n\nResidential income\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n24,545 (18%)\n750 (11%)\n8,325 (45%)\n5,830 (31%)\n1,535 (19%)\n\n\n\n\n    $52,000 - $65,999\n32,625 (25%)\n1,045 (16%)\n4,080 (22%)\n4,815 (26%)\n1,510 (19%)\n\n\n\n\n    $66,000 - $87,999\n36,680 (28%)\n1,605 (24%)\n3,555 (19%)\n4,565 (24%)\n2,025 (25%)\n\n\n\n\n    $88,000 or more\n39,255 (29%)\n3,195 (48%)\n2,360 (13%)\n3,470 (19%)\n2,885 (36%)\n\n\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Medicaid\n11,420 (8.5%)\n1,140 (17%)\n4,060 (22%)\n5,180 (27%)\n1,585 (19%)\n\n\n\n\n    Medicare\n55,415 (41%)\n1,655 (25%)\n6,640 (36%)\n4,605 (24%)\n2,225 (27%)\n\n\n\n\n    Other\n6,695 (5.0%)\n405 (6.1%)\n1,595 (8.6%)\n2,430 (13%)\n725 (8.8%)\n\n\n\n\n    Private\n60,990 (45%)\n3,470 (52%)\n6,340 (34%)\n6,835 (36%)\n3,680 (45%)\n\n\n\n\nAdmission type\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Elective\n64,765 (48%)\n3,300 (49%)\n6,780 (36%)\n7,530 (39%)\n3,860 (47%)\n\n\n\n\n    Non-elective\n69,880 (52%)\n3,375 (51%)\n11,900 (64%)\n11,550 (61%)\n4,370 (53%)\n\n\n\n\nNo. of comorbidities\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    No comorbidities\n27,170 (20%)\n2,015 (30%)\n4,025 (22%)\n4,230 (22%)\n1,790 (22%)\n\n\n\n\n    One comorbidity\n10,690 (7.9%)\n740 (11%)\n2,230 (12%)\n1,890 (9.9%)\n710 (8.6%)\n\n\n\n\n    Two or more comorbidities\n96,940 (72%)\n3,920 (59%)\n12,435 (67%)\n12,985 (68%)\n5,755 (70%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n33,320 (25%)\n680 (10%)\n3,320 (18%)\n1,350 (7.1%)\n835 (10%)\n\n\n\n\n    Northeast\n28,455 (21%)\n1,300 (19%)\n3,260 (17%)\n3,105 (16%)\n2,675 (32%)\n\n\n\n\n    South\n45,420 (34%)\n1,260 (19%)\n10,435 (56%)\n7,540 (39%)\n2,795 (34%)\n\n\n\n\n    West\n27,605 (20%)\n3,435 (51%)\n1,675 (9.0%)\n7,110 (37%)\n1,950 (24%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n\n\n0.10\n\n\n    Large\n94,975 (70%)\n4,720 (71%)\n12,620 (68%)\n13,120 (69%)\n6,045 (73%)\n\n\n\n\n    Medium\n26,420 (20%)\n1,305 (20%)\n4,225 (23%)\n4,280 (22%)\n1,480 (18%)\n\n\n\n\n    Small\n13,405 (9.9%)\n650 (9.7%)\n1,845 (9.9%)\n1,705 (8.9%)\n730 (8.8%)\n\n\n\n\nHospital location/teaching\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n2,605 (1.9%)\n20 (0.3%)\n220 (1.2%)\n70 (0.4%)\n50 (0.6%)\n\n\n\n\n    Urban, non-teaching\n9,765 (7.2%)\n590 (8.8%)\n1,100 (5.9%)\n1,705 (8.9%)\n430 (5.2%)\n\n\n\n\n    Urban, teaching\n122,430 (91%)\n6,065 (91%)\n17,370 (93%)\n17,330 (91%)\n7,775 (94%)\n\n\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Who Pays the Price? Race, Socioeconomic Factors, and Outcomes in Intracranial Tumor Care",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWhite N = 134,8001\nAsian or Pacific Islander N = 6,6751\nBlack N = 18,6901\nHispanic N = 19,1051\nOther N = 8,2551\np-value2\n\n\n\n\nDied during hospitalization\n1,920 (1.4%)\n195 (2.9%)\n480 (2.6%)\n425 (2.2%)\n220 (2.7%)\n&lt;0.001\n\n\nLength of stay (days)\n4.0 (2.0, 7.0)\n4.0 (2.0, 8.0)\n5.0 (3.0, 9.0)\n4.0 (2.0, 8.0)\n4.0 (3.0, 8.0)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n94,256 (50,102, 159,880)\n124,803 (61,676, 207,696)\n98,239 (45,734, 178,458)\n118,803 (59,106, 204,985)\n109,795 (54,572, 181,262)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Who Pays the Price? Race, Socioeconomic Factors, and Outcomes in Intracranial Tumor Care",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nIn-Hospital Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n2.65\n1.87, 3.75\n&lt;0.001\n\n\n    Black\n1.91\n1.49, 2.45\n&lt;0.001\n\n\n    Hispanic\n1.72\n1.33, 2.23\n&lt;0.001\n\n\n    Other\n1.98\n1.35, 2.90\n&lt;0.001\n\n\nAge, y\n0.99\n0.99, 1.00\n0.056\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.24\n1.06, 1.45\n0.009\n\n\nTumor location\n\n\n\n\n\n\n\n\n    Brain and central nervous system\n—\n—\n\n\n\n\n    Eye and adnexa\n0.44\n0.14, 1.35\n0.2\n\n\n    Meninges\n1.18\n0.77, 1.81\n0.4\n\n\nTumor type\n\n\n\n\n\n\n\n\n    Benign\n—\n—\n\n\n\n\n    Malignant\n2.27\n1.44, 3.58\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.15\n0.91, 1.45\n0.3\n\n\n    $66,000 - $87,999\n1.07\n0.85, 1.36\n0.6\n\n\n    $88,000 or more\n1.00\n0.78, 1.28\n&gt;0.9\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n0.90\n0.68, 1.20\n0.5\n\n\n    Other\n1.09\n0.76, 1.56\n0.6\n\n\n    Private\n0.86\n0.66, 1.10\n0.2\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n1.91\n1.38, 2.64\n&lt;0.001\n\n\nElixhauser comorbidity index\n1.30\n1.25, 1.35\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.71\n1.23, 2.37\n0.001\n\n\n    South\n0.91\n0.71, 1.16\n0.4\n\n\n    West\n1.16\n0.88, 1.52\n0.3\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.17\n0.95, 1.44\n0.14\n\n\n    Small\n1.94\n1.28, 2.93\n0.002\n\n\nHospital location/teaching\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.28\n0.17, 0.45\n&lt;0.001\n\n\n    Urban, teaching\n0.27\n0.18, 0.41\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Who Pays the Price? Race, Socioeconomic Factors, and Outcomes in Intracranial Tumor Care",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.94\n0.50, 1.4\n&lt;0.001\n\n\n    Black\n1.0\n0.63, 1.4\n&lt;0.001\n\n\n    Hispanic\n0.35\n0.03, 0.67\n0.034\n\n\n    Other\n0.94\n0.44, 1.4\n&lt;0.001\n\n\nAge, y\n-0.05\n-0.06, -0.04\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.11\n-0.07, 0.29\n0.2\n\n\nTumor location\n\n\n\n\n\n\n\n\n    Brain and central nervous system\n—\n—\n\n\n\n\n    Eye and adnexa\n-1.2\n-2.0, -0.36\n0.005\n\n\n    Meninges\n-0.22\n-0.52, 0.08\n0.15\n\n\nTumor type\n\n\n\n\n\n\n\n\n    Benign\n—\n—\n\n\n\n\n    Malignant\n-0.88\n-1.2, -0.57\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.21\n-0.47, 0.04\n0.10\n\n\n    $66,000 - $87,999\n-0.05\n-0.32, 0.22\n0.7\n\n\n    $88,000 or more\n-0.18\n-0.45, 0.09\n0.2\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n-1.0\n-1.5, -0.56\n&lt;0.001\n\n\n    Other\n-1.0\n-1.5, -0.52\n&lt;0.001\n\n\n    Private\n-1.6\n-2.0, -1.2\n&lt;0.001\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n2.1\n1.9, 2.3\n&lt;0.001\n\n\nElixhauser comorbidity index\n1.0\n0.97, 1.1\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.85\n0.51, 1.2\n&lt;0.001\n\n\n    South\n0.11\n-0.17, 0.39\n0.5\n\n\n    West\n-0.27\n-0.57, 0.03\n0.078\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.52\n-0.75, -0.29\n&lt;0.001\n\n\n    Small\n-0.49\n-0.99, 0.01\n0.054\n\n\nHospital location/teaching\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n-0.51\n-1.7, 0.66\n0.4\n\n\n    Urban, teaching\n0.19\n-0.95, 1.3\n0.7\n\n\n\n1 CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation-Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n18,862\n9,052, 28,672\n&lt;0.001\n\n\n    Black\n5,881\n-106, 11,867\n0.054\n\n\n    Hispanic\n18,727\n11,549, 25,905\n&lt;0.001\n\n\n    Other\n19,941\n7,153, 32,729\n0.002\n\n\nAge, y\n-1,480\n-1,676, -1,285\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n3,871\n840, 6,902\n0.012\n\n\nTumor location\n\n\n\n\n\n\n\n\n    Brain and central nervous system\n—\n—\n\n\n\n\n    Eye and adnexa\n-39,332\n-52,190, -26,475\n&lt;0.001\n\n\n    Meninges\n-4,752\n-10,456, 952\n0.10\n\n\nTumor type\n\n\n\n\n\n\n\n\n    Benign\n—\n—\n\n\n\n\n    Malignant\n-39,592\n-46,100, -33,085\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n58\n-4,258, 4,374\n&gt;0.9\n\n\n    $66,000 - $87,999\n-37\n-4,748, 4,674\n&gt;0.9\n\n\n    $88,000 or more\n6,326\n103, 12,549\n0.046\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n-2,011\n-9,431, 5,409\n0.6\n\n\n    Other\n-8,827\n-17,738, 84\n0.052\n\n\n    Private\n-6,860\n-13,554, -165\n0.045\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n-766\n-4,927, 3,395\n0.7\n\n\nElixhauser comorbidity index\n15,270\n13,934, 16,605\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n32,322\n22,574, 42,069\n&lt;0.001\n\n\n    South\n9,414\n2,462, 16,367\n0.008\n\n\n    West\n54,823\n45,477, 64,170\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-16,586\n-22,924, -10,249\n&lt;0.001\n\n\n    Small\n-24,922\n-33,126, -16,718\n&lt;0.001\n\n\nHospital location/teaching\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n47,737\n37,165, 58,309\n&lt;0.001\n\n\n    Urban, teaching\n57,965\n49,430, 66,500\n&lt;0.001\n\n\n\n1 CI = Confidence Interval"
  }
]